We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $27.1B
1-Year Est. Return 20.2%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.19%
AUM
$27.1B
AUM Growth
+$2.1B
Cap. Flow
+$4.87M
Cap. Flow %
0.02%
Top 10 Hldgs %
39.99%
Holding
700
New
54
Increased
201
Reduced
274
Closed
35

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$132M
2
NVDA icon
NVIDIA
NVDA
+$67.5M
3
MRSH
Marsh
MRSH
+$62.9M
4
GS icon
Goldman Sachs
GS
+$61.9M
5
MNST icon
Monster Beverage
MNST
+$60.8M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$78.9M
2
ACN icon
Accenture
ACN
+$78.2M
3
ORLY icon
O'Reilly Automotive
ORLY
+$75.1M
4
BRO icon
Brown & Brown
BRO
+$69.8M
5
BR icon
Broadridge
BR
+$65.4M

Sector Composition

Rank Sector Weight
1 Technology 26.91%
2 Financials 18.06%
3 Healthcare 13.92%
4 Communication Services 9.24%
5 Consumer Discretionary 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEPG icon
651
PepGen
PEPG
$218M
$57.6K ﹤0.01%
32,003
VZLA
652
Vizsla Silver
VZLA
$1.4B
$56.1K ﹤0.01%
17,100
-15,000
-47% -$52.1K
BMEA icon
653
Biomea Fusion
BMEA
$144M
$54.4K ﹤0.01%
37,000
IOVA icon
654
Iovance Biotherapeutics
IOVA
$3.93B
$53.5K ﹤0.01%
12,854
HAIN icon
655
Hain Celestial
HAIN
$67.5M
$49.5K ﹤0.01%
88,280
EU
656
enCore Energy
EU
$241M
$45.9K ﹤0.01%
35,000
LCTX icon
657
Lineage Cell Therapeutics
LCTX
$276M
$45.9K ﹤0.01%
35,000
AUTL
658
Autolus Therapeutics
AUTL
$596M
$44.9K ﹤0.01%
28,050
SOC icon
659
Sable Offshore Corp
SOC
$927M
$32.9K ﹤0.01%
10,670
URG
660
Ur-Energy
URG
$553M
$17.6K ﹤0.01%
13,000
-7,000
-35% -$11.4K
BGL
661
Blue Gold Ltd
BGL
$8.39M
$14.3K ﹤0.01%
51,246
+30,000
+141% +$25K
TRX icon
662
TRX Gold Corp
TRX
$383M
$11.6K ﹤0.01%
14,000
ORIO
663
Orion Digital Corp
ORIO
$23.8M
$8.99K ﹤0.01%
10,333
BYND icon
664
Beyond Meat
BYND
$193M
$8.62K ﹤0.01%
383
-5
-1% -$117
SRXH
665
SRX Global
SRXH
$30.6M
$1.81K ﹤0.01%
333
ARCC icon
666
Ares Capital
ARCC
$14.4B
-12,571
Closed -$227K
ASM
667
Avino Silver & Gold Mines
ASM
$1.26B
-21,100
Closed -$134K
BBU
668
DELISTED
Brookfield Business Partners
BBU
-13,437
Closed -$423K
BLFS icon
669
BioLife Solutions
BLFS
$1.72B
-77,086
Closed -$1.47M
BR icon
670
Broadridge
BR
$19.8B
-402,622
Closed -$65.4M
BTU icon
671
Peabody Energy
BTU
$3.52B
-7,295
Closed -$240K
DOCU
672
DocuSign
DOCU
$13B
-4,975
Closed -$236K
DOW icon
673
Dow Inc
DOW
$21.4B
-6,715
Closed -$280K
DRD
674
DRDGold
DRD
$2.47B
-16,575
Closed -$487K
EC icon
675
Ecopetrol
EC
$35.5B
-32,650
Closed -$489K

Similar funds

Rathbones Group's Q2 2026 Portfolio in Review

As of Q2 2026, Rathbones Group held 700 positions worth $27.1B, up 8.4% from $25B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rathbones Group's Q2 2026 filing shows 54 new, 201 increased, 274 reduced and 35 closed positions. Its largest new stake was Monster Beverage: 1,447,724 shares worth $69.6M. The largest sale was Intuit, an estimated $78.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Rathbones Group's largest Q2 2026 buy was Monster Beverage: 1,447,724 shares worth $69.6M.
  • Rathbones Group added most to Lam Research in Q2 2026, an estimated $132M increase.
  • Rathbones Group's biggest Q2 2026 reduction was Intuit, cutting an estimated $78.9M.
  • Rathbones Group fully exited Broadridge in Q2 2026, selling an estimated $65.4M.
  • Rathbones Group's ten largest holdings make up 40% of its $27.1B portfolio in Q2 2026.
  • Rathbones Group opened 54 new positions and closed 35 in Q2 2026.
  • Rathbones Group's portfolio value rose 8.4% quarter-over-quarter to $27.1B.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.